ARI 
 JRI 
 ISERB 
blogger delicious digg diigo facebook googleplus linkedin netlog reddit twitter
Skip Navigation LinksJRI > Archive > July-September 2005, Volume 6, Issue 3 > Comparing the effectiveness of two methods of oxytocin infusion in preventing atonic uterus



Volume 6, Issue 3, Number 23 / July-September
(pages 240-246)


Comparing the effectiveness of two methods of oxytocin infusion in preventing atonic uterus




 Corresponding Author
Department of Obs. & Gyn., Shahid Sadoughi Hospital, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Department of Obs. & Gyn., Shahid Sadoughi Hospital, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Department of Midwifery, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Department of Obs. & Gyn., Shahid Sadoughi Hospital, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


Related Articles
in Google Scholar in PubMed

 

Other Format
pdfPDF Full Text (En) pdfPDF Full Text (Fa) pdfePUB Full Text (En) pdfPDF Abstract (En) pdfPDF Abstract (Fa) pdf BibTeX pdfRefMan pdfEndNote xmlPMC XML online readerPMC Reader

 


Abstract
Introduction: Postpartum hemorrhage is one of the main causes of death in women, especially in deve-loping countries. The prevalence of postpartum bleeding is reported to be between 2-6% in normal and 0.6% in caesarian deliveries. Atonic uterus is responsible for 75-90% of postpartum bleedings, and in case the condition in not corrected, the risk of mortality increases considerably. Oxytocin is one of the commonly available drugs with minimal side-effects for the control of atonic uteri. The objective of this study was to compare the effectiveness of two different dosages of oxytocin in preventing atonic uteri. Materials and Methods: This is a clinical trial study performed on 566 patients who referred for normal vaginal deliveries or C/S to the labor ward of Sadoughi and Mojibian Hospital from late September to early March in 2003. The cases were randomly allocated to two groups. Both groups were similar regarding the risk factors for atonic uteri. Those in group I were each given 20 units while those in group II 100 units of oxytocin in 500 milliliters of Ringers solution. The infusion was started 1 minute after expulsion of the fetus and continued for half an hour. The bleeding rate, uterine contraction, blood pressure, need for transfusion and hematocrit of patients during the first stage of labor and 6 hours postpartum were assessed and recorded. Results were analyzed by using SPSS software, descriptive statistics and 2 statistical test. The significance level was considered 0.05. Results: In the low dosage oxytocin group (group I) 16 cases (5.7%) experienced atonia, while in group II with a higher dosage of oxytocin only 2 cases (0.7%) had atonia (p<0.001). In group I, 10 cases (6.5%) and in group II, 1 case (0.6%) needed manual placental removal (p<0.005). Fall in HCT was higher in group I (41.4%) as compared to group II (17.1%) and the difference was statistically significant (p<0.001). Despite the higher fall in blood pressure in group I (13.6%) as compared to group II (8.8%), the difference between the two groups was not statistically significant (p<0.072). Conclusion: Infusions of high doses of oxytocin (3330mU/min) as compared to low doses of the drug, (666mU/min) over half an hour after delivery result in decreased rates of atonia and need for manual removal of placenta and also decreased fall of hematocrit postpartum. This mode of treatment had no special side-effects or complications. Therefore, based on the results of this study, use of high doses of oxytocin in comparison with various prostaglandins and methyl ergonovine, is cheaper, more available and with fewer complications, especially in developing countries.

Keywords: Atonic uterus, Oxytocin, Caesarian section, Normal vaginal delivery, Postpartum hemorrhage, Manual removal of uterus, Hematocrit, Third and fourth stages of labor


To cite this article:


References
  1. Shane B., Burns M., Dahlquist K. Preventing post-partum Hemorrhage: managing the third stage of labor. Out look.2001;19(3):1-8.
  2. Cunningham F.G., Norman F.G., Kenneth J.L., et al. Obstetrical Hemorrhage. Williams Obstetrics. 21th Edi-tion. New York, MC Graw Hill.2001;PP:619-671.
  3. Elbourne D.R., Prendiville W.J., Carroli G. Prophlactic of oxytocin in the third stage of labour. Cochrane syst Rev.2001;(4):CD 001808.
  4. Gary A., Dildy III M.D. Postparum Hemorrhage: New management options. Clin Obstet Gynecol.2002;45(2): 330-344.
  5. James D. K., Street P.J. Postpartum hemorrhage and other problems of the third stage. High risk pregnancy. 2nd Edition.W.B Saunders, London.2000;pp:231-1247.
  6. Mc Donald S., Abbott J.M., Higgins S.P. Prophylactic ergometrine- oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev.2004;(1): CD 000201.
  7. Combs A.C., Murphy E.l., Laros R.K. Factors asso-ciated with postpartum hemorrhage: management of primary postpartum hemorrhage. Br J Obstet Gynecol. 1997;104:275-7.
  8. Cunningham F. G., Norman F. G., Kenneth J. L., et al. Conduct of Normal labor and delivery. Williams Obs-tetrics. 21th Editien. New York, MC Graw Hill.2001; pp: 309-331.
  9. Munn M.B., Owen J., Vincent R., et al. Comparison of two oxytocin regimens to prevent uterine atony at cesa-rean delivery: A randomized controlled trial. Obstet Gynecol.2001;98:386-390.
  10. Joy S.D., Sanchez- Ramos L. Misoprostol use during the third stage of labour. Int J Gynecol Obstet.2003;82 (2):43-152.
  11. P.S. Ng., Chan A.S., Sin W.K., TANg L.C., Cheung K. B. A multicenter randomized controlled trial of oral misoprostel and IM syntometrine in the management of the third stage of labour.Hum Reprod:2001;16(1):31-5.
  12. Huh W.K., Chelmow D., Malone F.D. A double blind-ed, randomized controlled trial of oxytocin at the begi-nning versus the end of the third stage of labor for prevention of postpartum hemorrhage. Gynecol Obstet Invest.2004;58(2):72-6.
  13. Cunningham F. G., Norman F. G., Kenneth J. L., et al. abortion. Williams obstetrics. 21th Editien. New York, MC Graw Hill.2001;pp: 855-883.
  14. Jackson K.W. Jr., Allbert J.R., Schemmer G.K., et al. A randomized controlled trail comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol.2001;185(4):873-877.
  15. Mc Comick M.L., Sanghvi H.C., Kinzie B., Mc Intash N. Preventing postpartum hemorrhage in low- resorce. Int J Gynaecol Obstet.2002;27(3):267-75.
  16. خوشيده مريم، شهرياري علي. مقايسه تأثير اكسي توسين و سنتومترين در جلوگيري از خونريزي بعد از زايمان. فصلنامه باروري و ناباروري، زمستان 82، صفحات: 61-52.
  17. Choy C.M., Lau W.C, Tam W.H. A randomized cont-rolled trial of intramascular syntometrine and intra-venous oxytocin in the management of the third stage of labour. BJOG.2002;109;(2):173-7.
  18. Oboro V.O., Tabowei T.O. A randomized controlled trial of misoprostal Versus oxytocin in the active management of the third stage of labour. J Obstet Gynaecol.2003;23(1):13-16.
  19. Gerstenfeld T.S., Wing D.A. Rectal misoprostol ver-sus intravenous oxytocin for the prevention of post-partum hemorrhage after vaginal delivery. Am J Obstet Gynecol.2001;185(4):878-82.
  20. Nordsrtom L., fogelstam K., Gridman G., et al. Rou-tine oxytocin in the third stage of labour: A placebo controlled randomized trial. Br J Obstet Gynecol.1997; 104:781-6.
  21. Prendiville W.J., Elbourne D., McDonald S. Active versus expectant management in the third stage of lab-oure.Cochrane Database system Rev.2000;(2):CD000 007.
  22. Chong, Y.S., Su L.L., Arulkumaran S. Current strate-gies for the prevention of postpartum hemorrhage in the third stage of labour. Curr opin Obstet Gynecol. 2004;16(2):143-50.
  23. Cunningham F.G.,Leveno K.J.,Bloom S.L.,Hauth J.C., Gilstrap L.C., Wenstrom K.D. Normal labor and deli-very. Williams Obstetrics. 22th Edition. New York, MC Graw Hill.2005;pp:409-441.



Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and copyrighted by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2016 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.